In Silico Prediction of the Phosphorylation of NS3 as an Essential Mechanism for Dengue Virus Replication and the Antiviral Activity of Quercetin

被引:6
|
作者
Alomair, Lamya [1 ,2 ,3 ]
Almsned, Fahad [2 ,3 ,4 ]
Ullah, Aman [2 ,3 ]
Jafri, Mohsin S. [2 ,3 ,5 ]
机构
[1] King Abdullah Int Med Res Ctr, Dept Biostat & Bioinformat, Bioinformat Sect, Riyadh 11481, Saudi Arabia
[2] George Mason Univ, Sch Syst Biol, Manassas, VA 22030 USA
[3] George Mason Univ, Krasnow Inst Adv Study, Manassas, VA 22030 USA
[4] King Fahad Specialist Hosp Dammam, Dammam 32253, Saudi Arabia
[5] Univ Maryland, Ctr Biomed Engn & Technol, Sch Med, Baltimore, MD 21201 USA
来源
BIOLOGY-BASEL | 2021年 / 10卷 / 10期
基金
美国国家卫生研究院;
关键词
dengue; NS3; phosphorylation; quercetin; NS2B-NS3 PROTEASE INHIBITION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SERINE-PROTEASE; FLAVIVIRUS; PROTEINS; HELICASE; LIGAND; SUBSTRATE; RESIDUES;
D O I
10.3390/biology10101067
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary:& nbsp;Dengue is a mosquito-borne virus that infects up to 400 million people worldwide annually. Dengue infection triggers high fever, severe body aches, rash, low platelet count, and could lead to Dengue hemorrhagic fever (DHF) in some cases. There is currently no cure, nor a broadly effective vaccine. The interaction of two viral proteins, nonstructural Proteins 3 and 5 (NS3 and NS5), is required for viral replication in the infected host's cells. Our computational modeling of NS3 suggested that phosphorylation of a serine residue at position 137 of NS3 by a specific c-Jun N-terminal kinase (JNK) enhances viral replication by increasing the interaction of NS3 and NS5 through structural changes in amino acid residues 49-95. Experimental studies have shown that inhibition of JNK prevents viral replication and have suggested that the plants' flavonoid Quercetin, Agathis flavone, and Myricetin inhibit Dengue infection. Our molecular simulations revealed that Quercetin binds NS3 and obstructs serine 137 phosphorylation, which may decrease viral replication. This work offers a molecular mechanism that can be used for anti-Dengue drug development.</p> & nbsp;</p> Dengue virus infection is a global health problem for which there have been challenges to obtaining a cure. Current vaccines and anti-viral drugs can only be narrowly applied in ongoing clinical trials. We employed computational methods based on structure-function relationships between human host kinases and viral nonstructural protein 3 (NS3) to understand viral replication inhibitors' therapeutic effect. Phosphorylation at each of the two most evolutionarily conserved sites of NS3, serine 137 and threonine 189, compared to the unphosphorylated state were studied with molecular dynamics and docking simulations. The simulations suggested that phosphorylation at serine 137 caused a more remarkable structural change than phosphorylation at threonine 189, specifically located at amino acid residues 49-95. Docking studies supported the idea that phosphorylation at serine 137 increased the binding affinity between NS3 and nonstructural Protein 5 (NS5), whereas phosphorylation at threonine 189 decreased it. The interaction between NS3 and NS5 is essential for viral replication. Docking studies with the antiviral plant flavonoid Quercetin with NS3 indicated that Quercetin physically occluded the serine 137 phosphorylation site. Taken together, these findings suggested a specific site and mechanism by which Quercetin inhibits dengue and possible other flaviviruses.</p>
引用
收藏
页数:27
相关论文
共 50 条
  • [21] NS3 of bluetongue virus interferes with the innate antiviral response
    Vitour, Damien
    Lara, Estelle
    Chauveau, Emilie
    Adam, Micheline
    Sailleau, Corinne
    Breard, Emmanuel
    Zientara, Stephan
    CYTOKINE, 2011, 56 (01) : 108 - 108
  • [22] Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity
    Hsieh, Ming-Shu
    Chen, Mei-Yu
    Hsieh, Chun-Hsiang
    Pan, Chien-Hsiung
    Yu, Guann-Yi
    Chen, Hsin-Wei
    PLOS ONE, 2017, 12 (11):
  • [23] Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity
    Bachmetov, L.
    Gal-Tanamy, M.
    Shapira, A.
    Vorobeychik, M.
    Giterman-Galam, T.
    Sathiyamoorthy, P.
    Golan-Goldhirsh, A.
    Benhar, I.
    Tur-Kaspa, R.
    Zemel, R.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (02) : E81 - E88
  • [24] The NS3 helicase RNA unwinding activity is critical for Hepatitis C Virus replication
    Lam, AMI
    Frick, DN
    FASEB JOURNAL, 2006, 20 (05): : A940 - A940
  • [25] Novel Dengue Virus NS2B/NS3 Protease Inhibitors
    Wu, Hongmei
    Bock, Stefanie
    Snitko, Mariya
    Berger, Thilo
    Weidner, Thomas
    Holloway, Steven
    Kanitz, Manuel
    Diederich, Wibke E.
    Steuber, Holger
    Walter, Christof
    Hofmann, Daniela
    Weissbrich, Benedikt
    Spannaus, Ralf
    Acosta, Eliana G.
    Bartenschlager, Ralf
    Engels, Bernd
    Schirmeister, Tanja
    Bodem, Jochen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 1100 - 1109
  • [26] Design and Docking Studies of Peptide Inhibitors as Potential Antiviral Drugs for Dengue Virus Ns2b/Ns3 Protease
    Velmurugan, Devadasan
    Mythily, Udhayakumar
    Rao, Kutumba
    PROTEIN AND PEPTIDE LETTERS, 2014, 21 (08): : 815 - 827
  • [27] Molecular Docking of Traditional Chinese Medicinal Compounds Against Dengue Virus NS3 Protease and NS3 Helicase
    Cadiz, Jewel Mae S.
    Susana, Christine Joy U.
    Endriga, Marla A.
    Frio, Enrique Jose L.
    2020 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE, 2020, : 1901 - 1908
  • [28] Molecular Dynamics of the Dengue Virus NS3/NS2b Protease
    Lima, Maria Carolina P.
    Seabra, Gustavo M.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 734A - 734A
  • [29] Novel ATP-Independent RNA Annealing Activity of the Dengue Virus NS3 Helicase
    Gebhard, Leopoldo G.
    Kaufman, Sergio B.
    Gamarnik, Andrea V.
    PLOS ONE, 2012, 7 (04):
  • [30] CRISPR-Cas13a Cleavage of Dengue Virus NS3 Gene Efficiently Inhibits Viral Replication
    Li, Hao
    Wang, Shan
    Dong, Xue
    Li, Qiao
    Li, Min
    Li, Junfeng
    Guo, Yan
    Jin, Xia
    Zhou, Yusen
    Song, Hongbin
    Kou, Zhihua
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 19 : 1460 - 1469